Country: Ireland
Language: English
Source: HPRA (Health Products Regulatory Authority)
Penciclovir
Chefaro Ireland DAC
D06BB; D06BB06
Penciclovir
1 %w/w
Cream
Product subject to prescription which may not be renewed (A)
Antivirals; penciclovir
Not marketed
2001-02-28
Package Leaflet CONFIDENTIAL Page 1 Vectavir Cold Sore Cream PACKAGE LEAFLET: INFORMATIOM FOR THE USER VECTAVIR COLD SORE CREAM Penciclovir READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor or pharmacist. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. WHAT IS IN THIS LEAFLET 1. What Vectavir is and what it is used for 2. What you need to know before you use Vectavir 3. How to use Vectavir 4. Possible side effects 5. How to store Vectavir 6. Contents of the pack and other information 1. WHAT VECTAVIR IS AND WHAT IT IS USED FOR Vectavir is used for the treatment of cold sores (Herpes labialis). A cold sore is caused by a viral infection. The virus can remain inactive for extended periods of time, but when triggered the virus multiplies and a cold sore develops. This can occur, for example when you are run-down, when you have a cold or flu, or when you have been out in strong sunlight. The virus causes painful blistering of the lips. Vectavir contains penciclovir and is an antiviral medicine which stops the virus multiplying. Applying Vectavir means your cold sore heals faster and the duration of pain will be shorter. The time your cold sore is infectious will also be shorter, although applying Vectavir will not stop you spreading your cold sores to another person. You must talk to a doctor if you do not feel better or if you feel worse after 4 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE VECTAVIR DO NOT USE VECTAVIR: If you are allergic to penciclovir, famciclovir or any of the other ingredients of Vectavir (listed in section 6). WARNINGS AND PRECAUTIONS Talk to your doctor or pharma Read the complete document
Health Products Regulatory Authority 29 November 2022 CRN00CPK4 Page 1 of 5 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Vectavir Cold Sore Cream 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of the cream contains 10 mg penciclovir. Excipients with known effect: cetostearyl alcohol, propyleneglycol. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Cream Smooth white cream of homogeneous appearance. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Vectavir Cold Sore Cream is indicated for the treatment of cold sores (herpes labialis) in adults (including older people) and children over 12 years of age. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology Adults (including older people)and children over12 years ofage: Vectavir Cold Sore Cream should be applied at approximately two hourly intervals during waking hours. Paediatric population Children (under 12 years): The safety and efficacy of Vectavir Cold Sore Cream in children below 12 years of age have not been established. No data are available. Method of administration Vectavir Cold Sore Cream may be applied with a clean finger, or with a single-use applicator (for packages which contain applicators), in the amount required for the size of the affected area of skin. Treatment should becontinued for 4 days. Treatment should be started as early as possible after the first sign of an infection. 4.3 CONTRAINDICATIONS Hypersensitivity to penciclovir, famciclovir or to any of theexcipients listed in section 6.1. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Health Products Regulatory Authority 29 November 2022 CRN00CPK4 Page 2 of 5 The cream should only be used on cold sores on the lips and around the mouth. It is not recommended for application to mucous membranes (e.g. in the eyes, mouth, or nose or on the genitals). Particular care should be taken to avoid application in or near the eyes. Severely immunocompromised patients (eg AIDs patients or bone marrow transplant recipients) should be encouraged to consult a ph Read the complete document